Urologic cancer in Indonesia

Area of Science:

• Urology
• Oncology
• Public Health

Background:

• Non-communicable diseases, particularly cancers, are increasingly prevalent in Indonesia.
• Malignant diseases show an annual incidence increase of up to 8%, becoming the seventh leading cause of death.
• Prostate, bladder, and kidney cancers are significant concerns, with many patients diagnosed at advanced stages.

Purpose of the Study:

• To highlight the rising incidence of urological cancers in Indonesia.
• To underscore the challenges posed by late-stage diagnoses for kidney, bladder, and prostate cancers.
• To emphasize the need for enhanced research and public education for early detection and prevention.

Main Methods:

• Analysis of cancer incidence data in Indonesia, including Globocan reports.
• Review of diagnostic and treatment patterns for kidney, bladder, and prostate cancers.
• Identification of common cancer types and associated risk factors like kidney and bladder stones.

Main Results:

• Kidney cancer often diagnosed in advanced stages; common treatments include radical or cytoreductive nephrectomy.
• Bladder cancer frequently presents as muscle-invasive disease, with high rates of patient refusal for radical treatment.
• Prostate cancer incidence is rapidly increasing, with most cases diagnosed late; treatment varies from surgery and radiotherapy to androgen deprivation therapy.

Conclusions:

• Urgent need for Indonesian urologists and healthcare providers to focus on earlier cancer diagnosis.
• Community education is vital for cancer prevention strategies.
• Further research is required to address the challenges of late-stage urological cancer diagnosis and treatment in Indonesia.